CONCLUSIONS: Stimulant shortage is highly prevalent and disrupt treatment continuity in children with ADHD in Turkey. Those with psychiatric comorbidities appear particularly sensitive to medication changes, with our findings formally demonstrating a synergistic interaction that amplifies clinical vulnerability. These results highlight the need for coordinated supply systems and targeted psychosocial support to mitigate the emotional and functional consequences of stimulant unavailability.
